Pivotal Evaluation of the Accuracy of a Biomarker Used for Classification or Prediction: Standards for Study Design
Open Access
- 15 October 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 100 (20), 1432-1438
- https://doi.org/10.1093/jnci/djn326
Abstract
Research methods for biomarker evaluation lag behind those for evaluating therapeutic treatments. Although a phased approach to development of biomarkers exists and guidelines are available for reporting study results, a coherent and comprehensive set of guidelines for study design has not been delineated. We describe a nested case–control study design that involves prospective collection of specimens before outcome ascertainment from a study cohort that is relevant to the clinical application. The biomarker is assayed in a blinded fashion on specimens from randomly selected case patients and control subjects in the study cohort. We separately describe aspects of the design that relate to the clinical context, biomarker performance criteria, the biomarker test, and study size. The design can be applied to studies of biomarkers intended for use in disease diagnosis, screening, or prognosis. Common biases that pervade the biomarker research literature would be eliminated if these rigorous standards were followed.Keywords
This publication has 19 references indexed in Scilit:
- Methods for Assessing Improvement in Specificity When a Biomarker is Combined With a Standard Screening TestStatistics in Biopharmaceutical Research, 2009
- Adjusting for Covariates in Studies of Diagnostic, Screening, or Prognostic Markers: An Old Concept in a New SettingAmerican Journal of Epidemiology, 2008
- Matching in Studies of Classification Accuracy: Implications for Analysis, Efficiency, and Assessment of Incremental ValueBiometrics, 2008
- How to improve reliability and efficiency of research about molecular markers: roles of phases, guidelines, and study designJournal of Clinical Epidemiology, 2007
- Biomarkers for Cancer Risk, Early Detection, and Prognosis: The Validation ConundrumCancer Epidemiology, Biomarkers & Prevention, 2007
- Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast CancerJNCI Journal of the National Cancer Institute, 2006
- Roadmap for Developing and Validating Therapeutically Relevant Genomic ClassifiersJournal of Clinical Oncology, 2005
- Clinical Trial Designs for Predictive Marker Validation in Cancer Treatment TrialsJournal of Clinical Oncology, 2005
- The winding road towards evidence based diagnosesJournal of Epidemiology and Community Health, 2002
- Evidence base of clinical diagnosis: Evaluation of diagnostic proceduresBMJ, 2002